Thyroid hormone changes in critical surgical illness: a narrative review

Authors

DOI:

https://doi.org/10.55791/5jvhf948

Keywords:

critical surgical illness, euthyroid sick syndrome, stress response, hypothalamic-pituitary-thyroid axis

Abstract

The systemic response to stress caused by a critical surgical illness is characterized by a series of events that precede metabolic and neuroendocrine dysregulation. However, the relevance of the
classically described 'stress response' is now highly questionable in an era where profound physiological deconditioning is common in critically ill, surgical and non-surgical patients. Common assessment techniques do not accurately reflect the integrity of the hypothalamic-pituitary-thyroid axis in the course of a critical chronic disease state. The clinical presentation is
mostly masked by symptoms of the underlying critical illness when plasma thyroid hormone concentrations are altered. The frequent development of multimorbidity in critically ill patients is the reason for the need for a more detailed analysis of the neuroendocrine model of activation. Basic scientific studies suggest that low levels of circulating thyroid hormones in the acute phase are an adaptive process, but the chronic condition could directly cause organ damage. Here, we review factors that have emerged to challenge the conventional model of euthyroid sick syndrome (ESS) in the surgically critically ill as an adaptive process, and suggest that the stage of the critical illness is an important consideration in the critically ill. Examining the stress
response in the critically ill presents opportunities to improve outcomes through improved understanding of the neuroendocrine aspects.

   

Author Biographies

  • Mirza Kovačević

    Department of Anesthesiology, Resuscitation and Intensive Care, Cantonal Hospital Zenica,
    Faculty of Medicine, Zenica, Bosnia and Herzegovina,

  • Višnja Nesek Adam

    University Department of Anesthesiology, Resuscitation and Intensive Care, Clinical Hospital Sveti Duh, Zagreb,
    Faculty of Medicine, Osijek, Croatia
    Faculty of Dental Medicine and Health, University of Josip Juraj Strossmayer, Osijek, Croatia

References

Smith SM, Vale WW. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci. 2006;8(4):383-95.

Kaptein EM, Sanchez A, Beale E, Chan LS. Clinical review: Thyroid hormone therapy for postoperative nonthyroidal illnesses: a systematic review and synthesis. J Clin Endocrinol Metab. 2010;95(10):4526-34.

Cauteruccio M, Vitiello R, Perisano C, Covino M, Sircana G, Piccirillo N, et al. Euthyroid sick syndrome in hip fractures: Evaluation of postoperative anemia. Injury. 2020;51(3):S9-S12.

Boonen E, Van den Berghe G. Endocrine Responses to Critical Illness: Novel Insights and Therapeutic Implications. J Clin Endocrinol Metab. 2014;99:5,1569–82.

Cheng SJ, Leonard JL, Davis PJ. Molecular Aspects of Thyroid Hormone Actions. Endocr Rev. 2010;31(2):139–70.

Wu Y, Xu B, Koenig RJ. Thyroid hormone response element sequence and the recruitment of retinoid X receptors for thyroid hormone responsiveness. J Biol Chem. 2001;276(6):3929-36.

Song Y, Yao X, Ying H. Thyroid hormone action in metabolic regulation. Protein Cell. 2011;2:358–68.

Ahmed RG. Genomic Actions of Thyroid Hormones during Development. Endocrinol Diabetes Metab J. 2018;4(1):5-8.

Bassett JHD. Thyroid hormone action: genomic and non-genomic effects. Endocrine Abstracts. 2011;25:S6.1.

Davis CT, Zhu W, Gibson CC, Bowman-Kirigin JA, Sorensen L, Ling J, et al. ARF6 inhibition stabilizes the vasculature and enhances survival during endotoxic shock. J Immunol. 2014;192(12):6045-52.

Leonard JL. Nongenomic Actions of Thyroid Hormone in Brain Development. Steroids. 2008;73(9-10):1008–12.

Anyetei-Anum CS, Roggero VR, Allison LA. Thyroid hormone receptor localization in target tissues. J Endocrinol. 2018;237:19-34.

Van den Berghe G. Non-thyroidal illness in the ICU: A syndrome with different faces. Thyroid. 2014;24:1456-65.

Stathatos N, Levetan C, Burman KD, Wartofsky L. The controversy of the treatment of critically ill patients with thyroid hormone. Best Pract Res Clin Endocrinol Metab. 2001;15:4; 465-78.

Lee J, Levy MM. Treatment of Patients with Severe Sepsis and Septic Shock: Current Evidence-Based Practices. R I Med J. 2019;102(10):18-21.

Plikat K, Langgartner J, Buettner R, Bollheimer LC, Woenckhaus U, Schflmerich J, et al. Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metab Clin Exp. 2007;56:239–44.

Bello G, Ceaichisciuc I, Silva S, Antonelli M. The role of thyroid dysfunction in the critically ill: a review of the literature. Minerva Anesthesiol. 2010;76:11.

Rodríguez-Rodríguez A, Lazcano I, Sánchez-Jaramillo E , Uribe RM, Jaimes-Hoy L, Joseph-Bravo P, et al. Tanycytes and the Control of Thyrotropin-Releasing Hormone Flux Into Portal Capillaries. Front Endocrinol. 2019;10:401.

Mohácsik P, Zeöld A, Bianco AC, Gereben B. Thyroid hormone and the neuroglia: both source and target. J Thyroid Res. 2011;2011:215718.

Bernal J. Action of thyroid hormone in brain. J Endocrinol Invest. 2002;25:268–88.

Lechan RM, Fekete C. Role of Thyroid Hormone Deiodination in the Hypothalamus. Thyroid. 2005;15:8.

Bondanelli M, Zatelli MC, Ambrosio MR, degli Uberti EC. Systemic illness. Pituitary. 2008;11(2):187-207.

Van den Berghe G. Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol. 2000;143:1.

Economidou F, Douka E, Tzanela M, Nanas S, Kotanidou A. Thyroid function during critical illness. Hormones (Athens). 2011;10(2):117-24.

Woo Kyung L, Sena H, Daham K, Seul GL, Seonhyang J, Mi-Youn S, et al. Distinct Features of Nonthyroidal Illness in Critically Ill Patients With Infectious Diseases. Medicine. 2016;95(14):pe3346.

Wajner SA, Goemann IM, Bueno AL, Larsen PR, Maia AL. IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells. J Clin Invest. 2011;121(5):1834-45.

Papanicolaou DA. Euthyroid Sick Syndrome and the Role of Cytokines. Rev Endocr Metab Disord. 2000;1:43-8.

De Vries EM, Fliers E, Boelen A. The molecular basis of the non-thyroidal illness syndrome. J Endocrinol. 2015;225,67–81.

Benvenga S. Thyroid hormone transport proteins and the physiology of hormone binding. Werner and Ingbar’s The Thyroid: A Fundamental and Clinical Text. Philadelphia, PA: Lippincott Williams & Wilkins. 2013;93-103.

Schussler GC. The thyroxine-binding proteins. Thyroid. 2000;10:141–9.

Jirasakuldech B, Schussler GC, Yap MG, Drew H, Josephson A, Michl J. A characteristic serpin cleavage product of thyroxine-binding globulin appears in sepsis sera. J Clin Endocrinol Metab. 2000;85:3996 –9.

Warner MH, Beckett GJ. Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol. 2010;205:1–13.

Fliers E, Boelen A. An update on nonthyroidal illness syndrome. J Endocrinol Invest. 2020.

Van der Deure WM, Peeters RP, Visser TJ. Molecular aspects of thyroid hormone transporters, including MCT8, MCT10, and OATPs, and the effects of genetic variation in these transporters. J Mol Endocrinol. 2010;44:1-11.

Visser WE, Friesema ECH, Visser TJ. Minireview: Thyroid hormone transporters: The knowns and the unknowns. Mol Endocrinol. 2011;25:1-14.

Michalaki M, Vagenakis AG, Makri M, Kalfarentzos F, Kyriazopoulou V. Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery. J Clin Endocrinol Metab.

;86(9):4198–205.

Mebis L, Paletta D, Debaveye Y , Ellger B, Langouche L , D'Hoore A , et al. Expression of thyroid hormone transporters during critical illness. Eur J Endocrinol. 2009;161(2):243-50.

Alkemade A, Friesema EC, Unmehopa UA, Fabriek BO, Kuiper GG, Leonard JL,et al. Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. J Clin Endocrinol Metab. 2005;90:4322–34.

Fekete C, Gereben B, Doleschall M, Harney JW, Dora JM, Bianco AC, et al. Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. Endocrinology. 2004;145:1649–55.

Boelen A, Kwakkel J, Wiersinga WM, Fliers E. Chronic local infammation in mice results in decreased TRH and type 3 deiodinase mRNA expression in the hypothalamic paraventricular nucleus independently of diminished food intake. J Endocrinol. 2006;191:707–14.

Boelen A, Kwakkel J, Chassande O, Fliers E. Thyroid Hormone Receptor beta mediates acute illness-induced alterations in central thyroid hormone metabolism. J Neuroendocrinol. 2009;21:465–72.

Debaveye Y, Ellger B, Mebis L, Darras VM, Van den BG. Regulation of tissue iodothyronine deiodinase activity in a model of prolonged critical illness. Thyroid. 2008;18:551–60.

Peeters RP, Wouters PJ, Kaptein E, van Toor H, Visser TJ, Van den Berghe G. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab. 2003;88:3202–11.

Boelen A, Boorsma J, Kwakkel J, Wieland CW, Renckens R, Visser TJ, et al. Type 3 deiodinase is highly expressed in infiltrating neutrophilic granulocytes in response to acute bacterial infection. Thyroid. 2008;18:1095–103.

Kwakkel J, Surovtseva OV, de Vries EM, Stap J, Fliers E, Boelen A. A novel role for the thyroid hormone-activating enzyme type 2 deiodinase in the inflammatory response of macrophages. Endocrinology. 2014;155:2725–34.

Van der Spek AH, Surovtseva OV, Jim KK, van Oudenaren A, Brouwer MC, Vandenbroucke-Grauls C, et al. Regulation of intracellular triiodothyronine is essential for optimal macrophage function. Endocrinology. 2018;159:2241–52.

Duyu A, Çıtak EC, Ak E, Küpeli S, Yağcı Küpeli B, Bayram İ, et al. Prevalence and Related Factors of Euthyroid Sick Syndrome in Children with Untreated Cancer According to Two Different Criteria. J Clin Res Pediatr Endocrinol. 2018;31;10(3):198-205.

Chatzitomaris A, Hoermann R, Midgley JE, Hering S, Urban A, Dietrich B, et al. Thyroid Allostasis–Adaptive Responses of Thyrotropic Feedback Control to Conditions of Strain, Stress, and Developmental Programming. Front Endocrinol (Lausanne). 2017;8:163.

Kim JG, Shin H, Kim W, Lim TH, Jang B, Cho Y, et al. The Value of Decreased Thyroid Hormone for Predicting Mortality in Adult Septic Patients: A Systematic Review and Meta-Analysis. Sci rep. 2018;8:14137.

Sharma S, Dabla PK, Kumar S, Dublis S. Thyroid hormone dysfunction and CRP levels in neonates with sepsis. J Endocrinol Metab. 2013;3:62-6.

Haas NA, Camphausen CK, Kececioglu D. Clinical review: Thyroid hormone replacement in children after cardiac surgery – is it worth a try? Crit Care. 2006;10:213.

Padhi R, Kabi S, Panda BN, Jagati S. Prognostic significance of nonthyroidal illness syndrome in critically ill adult patients with sepsis. Int J Crit Illn Inj Sci. 2018;8(3):165–72.

Wang F, Pan W, Wang H, Wang S, Pan S, Ge J. Relationship between thyroid function and ICU mortality: a prospective observation study. Crit Care. 2012;16(1):11.

De Luca R, Davis PJ, Lin H-Y, Gionfra F, Percario ZA, Affabris E, et al. Thyroid Hormones Interaction With Immune Response, Inflammation and Non-thyroidal Illness Syndrome. Front. Cell Dev Biol. 2021;8:614030.

Peeters RP, Wouters PJ, Van Toor H, Kaptein E, Visser TJ, Van Den Berghe G. Serum rT3 and T3/rT3 are prognostic markers in critically ill patients and are associated with post-mortem tissue deiodinase activities. J Clin Endocrinol Metab. 2005;90:4559–65.

Downloads

Published

29.04.2024

How to Cite

Thyroid hormone changes in critical surgical illness: a narrative review. (2024). South-East European Endo-Surgery Journal, 3(1). https://doi.org/10.55791/5jvhf948